|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [635]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [635]
DiMascio, A., Weissman, M. M., Prusoff, B. A., Neu, C., Zwilling, M., & Klerman, G. L. (1979). Differential symptom reduction by drugs and psychotherapy in acute depression. Archives of General Psychiatry, 36, 1450–1456.
Dobson, K. S. (1989). A meta-analysis of the efficacy of cognitive therapy for depression. Journal of Consulting and Clinical Psychology, 57, 411–419.
Dohrenwend, B. P., Levav, I., Shrout, P. E., Schwartz, S., Naveh, G., Link, B. G., et al. (1992). Socioeconomic status and psychiatric disorders: The causation–selection issue. Science, 255, 946–952.
Dube, S. R., Anda, R. F., Felitti, V. J., Chapman, D. P., Williamson, D. F., & Giles, W. H. (2001). Childhood abuse, household dysfunction, and the risk of attempted suicide throughout the lifespan: Findings from the Adverse Childhood Experiences Study. Journal of the American Medical Association, 286, 3089–3096.
Ehlers, C. L., Frank, E., & Kupfer, D. J. (1988). Social zeitgebers and biological rhythms. A unified approach to understanding the etiology of depression. Archives of General Psychiatry, 45, 948–952.
Elkin, I., Gibbons, R. D., Shea, T., Sotsky, S. M., Watkins, J. T., Pilkonis, P. A., et al. (1995). Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Journal of Consulting and Clinical Psychology, 63, 841–847.
Elkin, I., Shea, M. T., Watkins, J. T., Imber, S. D.,
Sotsky, S. M., Collins, J. F., et al. (1989). National Institute of Mental Health Treatment of Depression Collaborative Research Program: General effectiveness of treatments. Archives of General Psychiatry, 46, 971–982.
Emslie, G. J., Heiligenstein, J. H., Hoog, S. L., Wagner, K. D., Findling, R. L., McCracken, J. T., et al., (2004). Fluoxetine treatment for prevention of relapse of depression in children and adolescents: A double blind, placebo-controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 1397–1405.
Emslie, G. J., Heiligenstein, J. H., Wagner, K. D., Hoog, S. L., Ernest, D. E., Brown, E., et al. (2002). Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1205–1215.
Emslie, G. J., Rush, A. J., Weinberg, W. A., Kowatch, R. A., Hughes, C. W., Carmody, T., Rintelmann, J. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54, 1031–1037.
Evans, M. D., Hollon, S. D., DeRubeis, R. J., Piasecki, J., Grove, W. M., Garvey, M. J., et al. (1992). Differential relapse following cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry, 49, 802–808.
Evans, D. L., & Nemeroff, C. B. (1983). The dexamethasone suppression test in mixed bipolar disorder. American Journal of Psychiatry140, 615–617.
Ewald, H., Degn, B., Mors, B., & Kruse, T. A. (1998a). Significant linkage between bipolar affective disorder and chromosome 12q24. Psychiatric Genetics, 3, 131–140.
Eysenck, H. J. (1947). Dimensions of personality. London: Kegan Paul.
Faedda, G., Baldessarini, R., Suppes, T., Tondo, L., Becker, I., & Lipschitz, D. S. (1995). Pediatric-onset bipolar disorder: A neglected clinical and public health problem. Harvard Review of Psychiatry, 3, 171–195.
end p.635
|
|
|
|
